LOGIN  |  REGISTER
Surmodics

Latest Health Technology Stock News

MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration

May 16
Last Trade: 0.22 0.0011 0.50

Dallas, Texas, May 16, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of erectile dysfunction (ED), hair growth and hormone replacement therapies today announced that it has recently reported noteworthy growth in both revenue and customer acquisition in the first quarter ended...Read more


Doximity Announces Fourth Quarter and Fiscal Year 2024 Financial Results

May 16
Last Trade: 23.74 -0.11 -0.46

Fiscal year 2024 total revenues of $475.4 million, up 13% year-over-year Fiscal year 2024 net income growth of 31% and adjusted EBITDA growth of 25% year-over-year Q4 total revenues of $118.1 million, up 6% year-over-year Q4 net income growth of 32% and adjusted EBITDA growth of 15% year-over-year SAN FRANCISCO / May 16, 2024 / Business Wire / Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals,...Read more


BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders

GAITHERSBURG, Md., May 16, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug discovery company using artificial intelligence (AI) and machine learning to enable the successful discovery and development of pharmaceuticals and biologics, today announced significant advancements in its collaboration with the Lieber Institute for Brain Development...Read more


HEALWELL AI Participates in Leading-Edge Research on Chronic Kidney Disease Highlighting the Potential of its AI Powered Clinical Co-Pilot

HEAWELL AI’s Clinical Co-Pilot technology participated in recently published evidence showing the integration of a highly accurate machine model for Chronic Kidney Disease (“CKD”) progression when paired with Electronic Health Record (“EHR”) linked clinical decision support, improves guideline-recommended testing in patients with CKD. HEALWELL’s subsidiary Khure Health (“Khure”) co-authored an abstract that was published this month in...Read more


Veeva Systems Introduces Vault Basics for Biotechs

May 16
Last Trade: 209.65 -1.73 -0.82

Delivers industry-leading Vault applications in a turnkey solution with no implementation costs for simple adoption PLEASANTON, Calif., May 16, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced the availability of Veeva Vault Basics, a new offering that includes technology, training, and support designed for biotechs. Vault Basics equips fast-growing companies to deploy industry-leading Veeva Vault applications with...Read more


LifeWallet Announces First Quarter 2024 Financial Results

May 15
Last Trade: 0.79 -0.0002 -0.03

CORAL GABLES, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. d/b/a LifeWallet (NASDAQ: LIFW) ("LifeWallet," or the "Company"), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, today announced financial results for the quarter ended March 31, 2024. LifeWallet will host a conference call and live webcast to review the Company’s first quarter 2024 results for investors and...Read more


Simulations Plus Releases GastroPlus® X, The Next Generation PBPK/PBBM Modeling & Simulation Software

May 15
Last Trade: 50.21 -0.05 -0.10

Redesigned platform offers ease-of-use, enhanced software engineering, and significant productivity gains for users LANCASTER, Calif. / May 15, 2024 / Business Wire / Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced the release of GastroPlus® X. Branded as GPX™, this new platform represents the...Read more


GoodRx and Kroger Sign Direct Contracting Agreement

May 15
Last Trade: 8.06 0.79 10.87

Companies now offering almost 50% more savings on most generics at more than 2,200 Kroger Family of Pharmacies SANTA MONICA, Calif. / May 15, 2024 / Business Wire / GoodRx (Nasdaq: GDRX), the leading destination for prescription savings in the U.S., today announced a new direct contracting agreement with The Kroger Co. to deliver improved prescription pricing at more than 2,200 Kroger family pharmacy locations nationwide. “We are...Read more


Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024

May 15
Last Trade: 0.59 0.02 3.86

LONDON and NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today reported financial results for the fiscal third quarter ended March 31, 2024. The Company made continued progress towards commercial adoption with...Read more


iCAD Reports Financial Results for First Quarter Ended March 31, 2024

May 15
Last Trade: 1.77 0.14 8.59

NASHUA, N.H., May 15, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three months ended March 31, 2024. First Quarter 2024 Highlights (Year over Year Performance): Total ARR was $9.0 million, up 10% Total revenues were $5.0 million, up...Read more


HEALWELL AI Reports Q1-2024 Financial Results

May 14
Last Trade: 1.50 0.00 0.00

HEALWELL AI achieved quarterly revenue from continuing operations of $4.58 million in Q1-2024, 132% higher compared to $1.97 million generated in Q1-2023 and 139% higher than $1.92 million generated in Q4-2023. Since its relaunch in Q4-2023 and its acquisition of Intrahealth, an enterprise class EHR service provider on February 1, 2024, the Company’s annual revenue run rate has more than doubled to over $20 million with the largest...Read more


Definitive Healthcare to Present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference

May 14
Last Trade: 5.50 -0.07 -1.26

FRAMINGHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Founder, Interim CEO, and Executive Chairman, Jason Krantz, will present at the J.P. Morgan Global Technology, Media and Communications Conference. The Definitive Healthcare presentation is scheduled for Tuesday, May 21, 2024, at 10:10...Read more


OptimizeRx Reports First Quarter 2024 Financial Results

May 14
Last Trade: 12.85 -0.32 -2.43

Q1 revenue of $19.7 million, increasing 51% year-over-year Q1 gross profit increased 64% year-over-year to $12.2 million with a gross margin of 62% Won 9 DAAP deals during Q1 WALTHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients,...Read more


Progyny to Present at BofA Securities 2024 Healthcare Conference and Leerink Partners Healthcare Crossroads Conference 2024

NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Progyny’s executives will participate in a fireside chat at the BofA Securities 2024 Healthcare Conference on Wednesday, May 15, 2024, at 5:00 P.M. Pacific Time / 8:00 P.M. Eastern Time. They will also participate in a fireside chat at the Leerink Partners...Read more


GE HealthCare and Medis Medical Imaging Announce Collaboration Focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease

May 14
Last Trade: 81.31 -0.60 -0.73

Collaboration seeks to advance precision care by providing an alternative, non-invasive approach to the assessment of coronary physiology. Both companies will focus on the integration of Medis QFR into GE HealthCare’s cath lab environment built around the Allia Platform to enable a seamless user experience. CHICAGO / May 14, 2024 / Business Wire / Today, GE HealthCare (Nasdaq: GEHC), a leading global medical technology, pharmaceutical...Read more


CareCloud Reports First Quarter 2024 Results

May 14
Last Trade: 2.51 0.28 12.56

Continued Focus on Cost Reduction, Profitability and Cash Flow SOMERSET, N.J., May 14, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company" or "CareCloud") (Nasdaq: CCLD, CCLDP and CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced financial and operational results for the three months ended March 31, 2024. First Quarter 2024 Financial...Read more


Akili Reports First Quarter 2024 Financial Results and Provides Business Update

May 14
Last Trade: 0.43 -0.0006 -0.14

Company announces full voluntary prepayment of debt and termination of Amended & Restated Loan and Security Agreement with Silicon Valley Bank Following recent restructuring, focusing efforts primarily on supporting existing customers, executing the amended agreement with Shionogi, and evaluating potential strategic alternatives BOSTON / May 14, 2024 / Business Wire / Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company,...Read more


Ontrak Health Announces 2024 First Quarter Financial Results

May 14
Last Trade: 0.28 0.01 4.22

Q1 Revenue of $2.7 million, up 6% year over year Q1 operating loss of $(4.3) million, a 41% improvement year over year Q1 adjusted EBITDA of $(3.4) million, a 38% improvement year over year Company announces state approval of a new customer agreement with a prominent regional Medicaid health plan for our full suite of solutions Company to Host Conference Call at 4:30 pm ET Today MIAMI / May 14, 2024 / Business Wire / Ontrak, Inc....Read more


Kovo HealthTech Announces Q4 and Annual Results

May 13
Last Trade: 0.04 0.00 0.00

Vancouver, British Columbia--(Newsfile Corp. - May 13, 2024) - Kovo HealthTech Corporation (TSXV: KOVO) (the "Company" "Kovo") - a leader in healthcare technology and Billing-as-a-Service - today reported its annual financial results for the period ending December 31, 2023. Key Metrics: Securing a $3.3 million equity investment in April 2023. Securing a US$7.0 million credit facility in April 2023. Successful completion of the...Read more


Augmedix Delivers 40% Revenue Growth for First Quarter of 2024

May 13
Last Trade: 1.23 0.04 3.36

SAN FRANCISCO, May 13, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three months ended March 31, 2024. “Augmedix delivered in-line first quarter performance, with 40% revenue growth, 143% net revenue retention and 47.1% gross margins,” commented Manny Krakaris, Augmedix CEO. “We are confident about our positioning within the...Read more


Mobile-health Network Solutions Expands Services to Malaysia

May 10
Last Trade: 2.12 0.00 0.00

SINGAPORE, May 10, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or “the Company”), a leading Asia-Pacific telehealth provider, today announced the establishment of a subsidiary in Malaysia. This strategic expansion signifies MNDR's commitment to delivering accessible and affordable healthcare services throughout Southeast Asia. Solidifying Regional Leadership The Malaysian subsidiary marks a pivotal...Read more


TruBridge Announces First Quarter 2024 Results

May 10
Last Trade: 9.25 0.30 3.35

MOBILE, Ala. / May 10, 2024 / Business Wire / TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company, today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights All comparisons are to the quarter ended March 31, 2023, unless otherwise noted Bookings of $23.6 million compared to $19.8 million Total revenue of $83.2 million compared to $86.2 million Revenue Cycle Management (RCM)...Read more


VitalHub Reports First Quarter 2024 Financial Results

May 9
Last Trade: 6.99 -0.13 -1.83

ARR up 21% YoY to $47.8 million Total Revenue up 21% to $15.3 million EBITDA up 56% YoY to $3.1 million TORONTO, May 09, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX:VHI) (OTCQX:VHIBF) announced today it has filed its Interim Condensed Consolidated Financial Statements and Management's Discussion and Analysis report for the three ended March 31, 2024, with the Canadian securities authorities. These...Read more


CareMax Reports First Quarter 2024 Results

May 9
Last Trade: 2.77 -0.05 -1.77

First Quarter Medicare Advantage Membership of 107,000, up 12% year-over-year First Quarter Total Revenue of $232.2 million, up 34% year-over-year Continuing to Explore Strategic Options to Maximize Value of Certain Assets and Generate Further Liquidity MIAMI / May 09, 2024 / Business Wire / CareMax, Inc. (NASDAQ: CMAX; CMAXW) (“CareMax” or the “Company”), a leading technology-enabled value-based care delivery system, today announced...Read more


Sharecare announces first quarter 2024 financial results and operational highlights

May 9
Last Trade: 0.78 0.02 3.18

ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their health in one place, today announced financial results for the quarter ended March 31, 2024. “As we report first quarter earnings, we are thrilled that our purpose-built digital navigation platform for Medicaid is launching on July 1, 2024, to approximately 750,000 Medicaid members,” said Brent...Read more


Evolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S.

May 9
Last Trade: 23.31 -0.24 -1.02

Digital cancer care platform Careology and Evolent (NYSE: EVH) to offer an innovative platform to enable cancer navigation Evolent will embed Careology's digital cancer care technology within its comprehensive care navigation services offered to health plan clients across the U.S. WASHINGTON, May 9, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a $2 billion revenue company focused on achieving better health outcomes for...Read more


Evolent Health Announces First Quarter 2024 Results

May 9
Last Trade: 23.31 -0.24 -1.02

Revenue of $639.7 million, an increase of $212.0 million or 49.6%, from the three months ended March 31, 2023. Net loss attributable to common shareholders of Evolent Health, Inc. of $(25.2) million and a net loss margin of (3.9)%. Adjusted EBITDA of $54.1 million resulting in an Adjusted EBITDA margin of 8.5%. Raises revenue outlook for full year 2024 and reiterates full year 2024 Adjusted EBITDA guidance. WASHINGTON, May 9, 2024...Read more


Health Catalyst Reports First Quarter 2024 Results

May 9
Last Trade: 7.03 0.25 3.69

SALT LAKE CITY, May 09, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2024. “For the first quarter of 2024, I am pleased by our strong financial results, including total revenue of $74.7 million and Adjusted EBITDA of $3.4 million, with...Read more


Progyny Announces First Quarter 2024 Results

May 9
Last Trade: 27.55 0.77 2.88

NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a transformative fertility, family building and women's health benefits solution, today announced its financial results for the three-month period ended March 31, 2024 (“the first quarter of 2024”) as compared to the three-month period ended March 31, 2023 (“the first quarter of 2023” or “the prior year period”). “Utilization...Read more


GoodRx Reports First Quarter 2024 Results

May 9
Last Trade: 8.06 0.79 10.87

SANTA MONICA, Calif. / May 09, 2024 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading destination for prescription savings in the U.S., has released its financial results for the first quarter of 2024. First Quarter 2024 Highlights Revenue1 and Adjusted Revenue1 of $197.9 million Net loss of $1.0 million; Net loss margin of 0.5% Adjusted Net Income1 of $32.6 million;...Read more


Privia Health Reports First Quarter 2024 Financial Results

May 9
Last Trade: 17.00 -0.37 -2.13

Practice Collections +7.4% compared to 1Q’23 Implemented Providers +17.3% compared to 1Q’23 Company Reiterated Full Year 2024 Guidance ARLINGTON, Va., May 09, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quarter ended March 31, 2024.   For the Three Months Ended March 31,         ($ in millions, except per share...Read more


TruBridge and Multiview Announce Preferred Partnership Making Enhanced Financial Management Solutions Available to TruBridge Clients

May 8
Last Trade: 9.25 0.30 3.35

MOBILE, Ala. / May 08, 2024 / Business Wire / TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company, and Multiview Financial Software (Multiview) announced a newly formed strategic partnership at TruBridge’s recent annual National Client Conference held in Las Vegas, Nevada. TruBridge announced Multiview’s cloud-based Enterprise Resource Planning (ERP) software as its preferred financial management solution for its clients, with...Read more


R1 RCM Reports First Quarter 2024 Results

May 8
Last Trade: 12.31 -0.19 -1.52

MURRAY, Utah, May 08, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months ended March 31, 2024 and updated full year 2024 outlook. First Quarter 2024 Results: Revenue of $603.9 million, up $58.3...Read more


MultiPlan Reports First Quarter 2024 Results

May 8
Last Trade: 0.60 -0.03 -5.01

Q1 2024 Revenues of $234.5 million, Net Loss of $539.7 million (including a $519.1 million impairment of goodwill and indefinite-lived intangible assets), and Adjusted EBITDA of $146.8 million Identified potential medical cost savings of approximately $5.7 billion in Q1 2024, up 3% from Q1 2023 and down 3% from Q4 2023 Repurchased or repaid $24.4 million of face value of debt, including $21.1 million of 6.0% Senior Convertible PIK...Read more


LifeSpeak Announces First Quarter 2024 Results

May 8
Last Trade: 0.63 0.00 0.00

First quarter 2024 revenue of $12.4 million Adjusted EBITDA1 for first quarter 2024 of $2.7 million and Adjusted EBITDA Margin1 of 22% Total Number of Clients2 of 914 as at March 31, 2024 TORONTO, May 8, 2024 /CNW/ - LifeSpeak Inc. ("LifeSpeak" or the "Company") (TSX: LSPK), the leading whole-person wellbeing solution for employers, health plans and other organizations, announced today its financial and operational...Read more


Certara Reports First Quarter 2024 Financial Results

May 7
Last Trade: 16.47 0.55 3.45

PRINCETON, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the first quarter of fiscal year 2024. First Quarter Highlights: Revenue was $96.7 million, compared to $90.3 million in the first quarter of 2023, representing growth of 7%.  Software revenue was $39.3 million, compared to $33.0 million in the first quarter of 2023,...Read more


Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2024

May 7
Last Trade: 5.50 -0.07 -1.26

FRAMINGHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended March 31, 2024.  First Quarter 2024 Financial Highlights: Revenue was $63.5 million, an increase of 7% from $59.2 million in Q1 2023.  Net Loss was $(12.7) million, or (20%) of...Read more


Cloud DX Signs Multi-Year Contract with Provincial Health Authority

May 7
Last Trade: 0.12 0.01 9.09

This agreement is the 4th Provincial Health Authority contract for Cloud DX remote patient monitoring (RPM) services, alongside Alberta, the Yukon and Prince Edward Island. News in Summary After a successful competitive RFP process, on April 23, 2024 the Company executed a Province-wide contract for Remote Patient Monitoring (RPM) products and services. The contract has a term of 36 months with 2 extensions of 12 months each. The...Read more


SOPHiA GENETICS Reports First Quarter 2024 Results

May 7
Last Trade: 4.61 -0.03 -0.65

BOSTON and ROLLE, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Highlights Revenue grew 13% year-over-year to $15.8 million; Constant currency revenue excluding COVID-related revenue grew 12% year-over-year Gross margins were 65.9%...Read more


Premier Reports Fiscal-Year 2024 Third-Quarter Results

May 7
Last Trade: 19.78 -0.11 -0.55

Reaffirming fiscal 2024 financial guidance ranges Executed $400 million accelerated share repurchase transaction CHARLOTTE, N.C. / May 07, 2024 / Business Wire / Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2024 third quarter ended March 31, 2024. Third-quarter results: Total net revenue of $342.6 million; growth of 6% over the...Read more


EUDA Health Expands into Direct Selling Holistic Wellness Products with Acquisition of CK Health

SINGAPORE, May 06, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, today announced that it will acquire CK Health Plus Sdn Bhd (“CK Health”), a direct seller of holistic wellness consumer products in Malaysia. Under the terms of the acquisition agreement, EUDA has...Read more


HEALWELL AI Announces Upsize of Bought Deal to Up to $20 Million

May 6
Last Trade: 1.50 0.00 0.00

TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI INC. (“HEALWELL” or the “Company”) (TSX: AIDX) is pleased to announce today that, due to strong demand, it has agreed with Clarus Securities Inc. (“Clarus”) and Eight Capital Corp. (“Eight”), as Co-Bookrunners and Co-Lead Underwriters (the “Co-Lead Underwriters”), on behalf of a syndicate of underwriters (collectively, the “Underwriters”), to increase the size of its previously...Read more


HEALWELL AI Announces $16 Million Bought Deal Private Placement

May 6
Last Trade: 1.50 0.00 0.00

TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. ("HEALWELL" or the "Company") (TSX: AIDX), a data science and AI company focused on preventative care, is pleased to announce that it has entered into an agreement pursuant to which Clarus Securities Inc. and Eight Capital, as lead underwriters and co-bookrunners, together with a syndicate of underwriters (collectively, the “Underwriters”), will purchase 11,851,900 units of the...Read more


Pushing the Boundaries of Neuroscience with GE HealthCare’s SIGNA MAGNUS

May 5
Last Trade: 81.31 -0.60 -0.73

SIGNA MAGNUSi is a high-performance head-only MR scanner from GE HealthCare that could expand the field of neuroscience, which has been limited by the performance of conventional whole-body MR systems thus far. This system is designed to advance MR research in complex imaging procedures in neurology, oncology & psychiatry. CHICAGO / May 05, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today unveiled SIGNA MAGNUS, an FDA...Read more


GE HealthCare Management to Present at Upcoming Investor Conferences

May 2
Last Trade: 81.31 -0.60 -0.73

CHICAGO / May 02, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC), is announcing that its Vice President and Chief Financial Officer, Jay Saccaro will be presenting at the following upcoming investor conferences. Bank of America Securities 2024 Healthcare Conference in Las Vegas – May 14, 2024 at 1:00 pm ET/10:00 am PT Jefferies Global Healthcare Conference in New York – June 5, 2024 at 10:00 am ET These events can be accessed at...Read more


10x Genomics to Present at the BofA Securities 2024 Healthcare Conference

May 2
Last Trade: 25.59 -0.80 -3.03

PLEASANTON, Calif., May 2, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will participate in a fireside chat at the BofA Securities 2024 Healthcare Conference on Tuesday, May 14, at 4:20 p.m. Pacific Time. Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at:...Read more


Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial

May 2
Last Trade: 5.75 0.00 0.00

RESEARCH TRIANGLE PARK, N.C., May 02, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. today disclosed the latest enrollment figures resulting from its Metasite™ and Patient Recruitment partnership with a leading biotech company whose asthma drug is currently undergoing a Phase 3 clinical trial. Leveraging its proprietary Metasite™ and Patient Recruitment solutions, Science 37 contributed 28% of all randomized study participants over a...Read more


Omnicell Announces First Quarter 2024 Results

May 2
Last Trade: 31.66 1.79 5.99

Results exceed prior first quarter guidance across all metrics Total GAAP revenues of $246 million FORT WORTH, Texas / May 02, 2024 / Business Wire / Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced results for its first quarter ended March 31, 2024. Randall Lipps, chairman, president, chief executive officer, and...Read more


Spok Reports First Quarter 2024 Results

May 1
Last Trade: 15.31 -0.01 -0.07

Total year-over-year revenue growth exceeds 5% Software year-over-year revenue growth over 15% Net income and adjusted EBITDA up 35.9% and 9.2%, respectively, from the prior year period ALEXANDRIA, Va. / May 01, 2024 / Business Wire / Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced results for the first quarter ended March 31, 2024. In addition, the Company’s Board of Directors...Read more


Amwell Announces Results For First Quarter 2024

May 1
Last Trade: 0.49 0.0075 1.57

Boston, May 01, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL) a small-cap, growth healthcare company and a leading provider of healthcare software as a service, today announced financial results for the first quarter ended March 31, 2024. Visit Amwell’s investor relations website at investors.amwell.com to view the first quarter 2024 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m....Read more


Schrödinger Reports First Quarter 2024 Financial Results

May 1
Last Trade: 22.90 -0.46 -1.97

First Quarter Total Revenue of $36.6 Million, Software Revenue of $33.4 Million Announces FDA Clearance of Investigational New Drug Application for SGR-3515, a Novel Wee1/Myt1 Inhibitor SGR-1505 and SGR-2921 on Track for Initial Phase 1 Data Readouts in Late 2024 or 2025 NEW YORK / May 01, 2024 / Business Wire / Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and...Read more


GE HealthCare Launches New Era of AI-Enhanced, Personalized Oncology Solutions at ESTRO 2024 Congress

May 1
Last Trade: 81.31 -0.60 -0.73

Company unveiling innovations which harness the power of AI to optimize the complex radiation therapy workflow and enable personalized, more timely care for patients across the cancer care continuum CHICAGO / May 01, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced Revolution RT,i a new radiation therapy computed tomography (CT) solution with innovative hardware and software solutions to help increase imaging...Read more


VitalHub Announces Strategic Leadership Appointments to Drive Continued Growth and Operational Excellence

May 1
Last Trade: 6.99 -0.13 -1.83

TORONTO, May 01, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX:VHI) (OTCQX:VHIBF) is pleased to announce significant organizational changes to further strengthen its leadership team as it prepares for accelerated growth and enhanced operational efficiency. The Company has promoted Patrick Mazza to Chief Operating Officer and Niels Tofting to Executive Vice President, Managing Director of North American...Read more


10x Genomics Reports First Quarter 2024 Financial Results

April 30
Last Trade: 25.59 -0.80 -3.03

PLEASANTON, Calif., April 30, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended March 31, 2024. Recent Highlights Revenue was $141.0 million for the first quarter, a 5% increase over the corresponding period of 2023, driven by Spatial revenue. Shipped Visium HD Spatial Gene Expression, enabling whole transcriptome...Read more


SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference

April 30
Last Trade: 4.61 -0.03 -0.65

BOSTON and ROLLE, Switzerland, April 30, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced that Chief Financial Officer and Chief Operating Officer, Ross Muken, will present at the 2024 RBC Capital Markets Global Healthcare Conference in New York City on Tuesday, May 14, 2024, at 3:35 p.m. EDT. The presentation will be webcast live on the SOPHiA GENETICS...Read more


GE HealthCare Reports First Quarter 2024 Financial Results

April 30
Last Trade: 81.31 -0.60 -0.73

Revenues declined 1% year-over-year; Organic revenue growth* was approximately flat Net income margin was 8.0% versus 7.9% for the prior year; Adjusted Earnings Before Interest and Taxes (EBIT) margin* was 14.7% versus 14.1% Diluted earnings per share (EPS) were $0.81 versus $0.41 for the prior year; Adjusted EPS* was $0.90 versus $0.85 Cash flow from operating activities was $419 million versus $468 million for the prior year; Free...Read more


GeneDx Reports First Quarter 2024 Financial Results and Business Highlights

April 29
Last Trade: 24.02 2.86 13.52

Reported first quarter 2024 revenue from continuing operations1 of $61.5M with 96% year-over-year growth of exome and genome test revenue Expanded first quarter 2024 adjusted gross margins2 from continuing operations to 61% Narrowed first quarter 2024 adjusted net loss2 to $8.5M and delivered 71% year-over-year cash burn reduction Raised guidance to deliver between $235M and $245M in FY 2024 revenue and reiterate path to...Read more


Cloud DX Reports FY2023 Results

April 29
Last Trade: 0.12 0.01 9.09

Highlights include 55.4% increase in total revenue, 69% increase in subscription revenue, 112.8% increase in gross profit, and 20.4% reduction in operating loss compared to FY2022. Key Developments: Total Revenue of $1,811,885 represents an increase of 55.4% compared to FY2022 due to increases in both new contracts signed and growth of existing contracts. Gross profit in FY2023 doubled from $602,896 to $1,282,680 compared to FY2022...Read more


Dr. David Rhew, Global Chief Medical Officer & Vice President of Healthcare at Microsoft, to Address Rural and Community Healthcare Professionals at TruBridge National Client Conference

April 29
Last Trade: 9.25 0.30 3.35

TruBridge Brings the Needs of Rural and Community Health to the Forefront in Collaboration with Microsoft MOBILE, Ala. / Apr 29, 2024 / Business Wire / TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company, will host their annual National Client Conference, “The Next Step,” April 29 - May 2, 2024, in Las Vegas, Nevada. Highlighting the collaboration with TruBridge and their commitment to the Trustworthy & Responsible AI...Read more


GE HealthCare Receives FDA Clearance for Portrait VSM, Building on Its Growing Ecosystem of Connected Patient Monitoring Solutions

April 29
Last Trade: 81.31 -0.60 -0.73

The portable vital signs monitor (VSM) adds to GE HealthCare’s growing Portrait Ecosystem to help clinicians make timely treatment decisions and detect patient deterioration earlier with a streamlined spot check workflow, while ensuring patient mobility. Portrait VSM uses proven and innovative capabilities to provide precise readings for blood pressure, pulse rate, oxygen saturation, body temperature and respiratory rate. CHICAGO /...Read more


Streamline Health Solutions Expands eValuator™ Footprint With Existing Client

April 29
Last Trade: 0.32 0.01 3.28

Following an efficient implementation process, a leading Florida-based healthcare provider is expanding its footprint and utilization of eValuator Atlanta, GA, April 29, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has expanded its existing contract with a 1,250 bed, Epic-based academic...Read more


Streamline Health Solutions Reports Fiscal Fourth Quarter and Full Year 2023 Financial Results

April 29
Last Trade: 0.32 0.01 3.28

14% growth of SaaS revenue in fiscal 2023 compared to fiscal 2022 $0.4 million of adjusted EBITDA generated in the fourth quarter of fiscal 2023 compared to ($0.2 million) during the fourth quarter of fiscal 2022; $2.4 million of adjusted EBITDA improvement in fiscal 2023 vs. fiscal 2022 ($1.4 million) net loss during the fourth quarter of fiscal 2023, compared to ($2.2 million) during the fourth quarter of fiscal 2022 $15.0 million...Read more


Teladoc Health Reports First Quarter 2024 Results

April 25
Last Trade: 12.90 0.09 0.70

PURCHASE, NY, April 25, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the three months ended March 31, 2024 (“First Quarter 2024”). Unless otherwise noted, percentage and other changes are relative to the three months ended March 31, 2023 (“First Quarter 2023”). Financial and Operational Highlights for First Quarter...Read more


Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2024

April 25
Last Trade: 7.33 -0.03 -0.41

SEATTLE, April 25, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal fourth quarter and full year ended February 29, 2024. "Accolade has built a rare healthcare services business at scale with consistently strong growth rates. Whether serving consumers, employers, health plans, or government entities, the core of our value proposition is making healthcare easier to access, navigate,...Read more


Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain

April 25
Last Trade: 0.33 0.05 17.99

LIFEHAB is a randomized controlled trial in Norway comparing lumbar interbody fusion surgery with multidisciplinary rehabilitation Norway is a single-payer national health insurance system LIFEHAB is targeting enrollment to begin in the second quarter of 2024 BROOMFIELD, CO, April 25, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW),a healthcare...Read more


Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care

April 25
Last Trade: 0.22 0.0011 0.50

Provides MangoRx with entrance into the non-Rx based, nutraceutical product space for sales on both direct-to-consumer online platforms and through retail locations Dallas, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of erectile dysfunction (ED), hair...Read more


Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments

SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced the general availability of Augmedix Go for emergency departments (EDs), marking the launch of the industry’s first fully-automated, generative AI (GenAI) powered medical documentation product for EDs across the country. The launch incorporates learnings from a pilot program with HCA...Read more


Cloud DX Signs Contract Renewals with 2 Ontario Community Paramedic Services Valued at $380,000

April 23
Last Trade: 0.12 0.01 9.09

Contract renewals reflect high customer satisfaction with Cloud DX Connected Health products and services across North America. News in Summary On April 4, 2024, Cloud DX renewed a 12-month Master Deployment Agreement with an Ontario County Paramedic Service and on April 18, 2024, Cloud DX renewed a 24-month Master Deployment Agreement with the Guelph Wellington - City of Guelph Paramedic Service.
 In Ontario, Remote Patient...Read more


Mobile-health Network and Online Pharmacy, Lifepack, Sign Partnership Facilitating Cooperation in Singapore and Indonesia

April 23
Last Trade: 2.12 0.00 0.00

SINGAPORE, April 23, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or the “Company”), a pioneering Asia-Pacific (“APAC”) telehealth provider, has announced a strategic partnership with PT Indopasifik Teknologi Medika Indonesia, better known as Lifepack, an online prescription provider based in Indonesia. The collaboration aims to improve healthcare accessibility in Indonesia by bringing affordable and...Read more


GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset

April 23
Last Trade: 24.02 2.86 13.52

STAMFORD, Conn., April 23, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a strategic partnership with Komodo Health, a premier healthcare technology company for the pharmaceutical industry. The new partnership will increase access to GeneDx's extensive de-identified rare disease data set, now available through Komodo Health’s MapEnhance offering,...Read more


SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa

April 23
Last Trade: 4.61 -0.03 -0.65

Syndicate Bio to implement new liquid biopsy offering to advance cancer diagnostics throughout Africa BOSTON and ROLLE, Switzerland, April 23, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Nigeria-based Syndicate Bio has signed on to implement MSK-ACCESS® powered with SOPHiA DDM™. Syndicate Bio is the first...Read more


HealthStream Announces First Quarter 2024 Results

April 22
Last Trade: 27.33 0.07 0.26

NASHVILLE, Tenn. / Apr 22, 2024 / Business Wire / HealthStream, Inc. (the “Company”) (Nasdaq: HSTM), a leading healthcare technology platform for workforce solutions, announced today results for the first quarter ended March 31, 2024. First Quarter 2024 Revenues of $72.8 million in the first quarter of 2024, up 6% from $68.9 million in the first quarter of 2023 Operating income of $5.7 million in the first quarter of 2024, up 97% from...Read more


GE HealthCare’s MIM Software collaborates with Elekta to help enhance radiation therapy treatments and improve patient outcomes

April 22
Last Trade: 81.31 -0.60 -0.73

Collaboration has always been important in the healthcare industry, but in this era of digital health, teamwork across institutions has become essential Enhancing Elekta’s radiation therapy offerings with GE HealthCare’s MIM Software medical imaging management solutions will help drive greater benefits for global healthcare systems This new collaboration complements GE HealthCare and Elekta’s existing global commercial collaboration...Read more


GE HealthCare Introduces AI-Enhanced Voluson Signature 20 and 18 Ultrasound Systems to Advance Women’s Health Imaging

April 18
Last Trade: 81.31 -0.60 -0.73

Integrated artificial intelligence (AI) and advanced tools improve image quality and exam speed to help providers make accurate diagnoses and tailor precision care for women Latest Voluson Signature ultrasound technology offers an intuitive and ergonomic design allowing clinicians to focus on patient care CHICAGO / Apr 18, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced the launch of the Voluson Signature 20 and 18...Read more


Veeva Systems Launches AI Partner Program

April 18
Last Trade: 209.65 -1.73 -0.82

Advanced technology and support to enable the development of GenAI solutions PLEASANTON, Calif., April 18, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced the Veeva AI Partner Program to provide partners with the advanced technology and support needed to integrate Generative AI (GenAI) solutions seamlessly with Veeva Vault applications. "Our customers are exploring GenAI solutions across many use cases...Read more


Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment

April 17
Last Trade: 5.75 0.00 0.00

RESEARCH TRIANGLE PARK, N.C., April 17, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc., the clinical research industry’s leading MetasiteTM, today announced the launch of a stand-alone Patient Recruitment Solution to deliver patients to sites that are eligible, medically reviewed, and fully consented. While traditional central patient recruitment campaigns have proven to be effective in accelerating enrollment, they are fraught with...Read more


CareCloud to Showcase Cutting-Edge Healthcare Technology Solutions at the 2024 Kansas MGMA Conference

April 17
Last Trade: 2.51 0.28 12.56

SOMERSET, N.J., April 17, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, is pleased to announce its participation in the 2024 Kansas MGMA Annual Conference, taking place from April 17-19 at the Wichita Marriott, Kansas. CareCloud will seize this opportunity to showcase its innovative solutions aimed at transforming...Read more


HEALWELL AI Subsidiaries, Khure Health & Pentavere Research Group, to Participate and Present at Upcoming Globally Recognized Medical Conferences

April 17
Last Trade: 1.50 0.00 0.00

Khure Health will be presenting at the National Kidney Foundation Spring Clinical Meetings on May 14-18, 2024 in Long Beach, CA. Pentavere will be presenting at the following medical conferences: Canadian Retina Society Annual Meeting on May 3-5, 2024 in Montreal, QC. American Head & Neck Society Annual Meeting on May 15-16, 2024 in Chicago, IL. American Medical Informatics Association (AMIA) Clinical Informatics Conference on...Read more


Biopharma Leaders Come Together at Veeva Systems Commercial Summit to Advance Customer-Centric Engagement

April 17
Last Trade: 209.65 -1.73 -0.82

Keynote speakers include leaders from Bayer, Genentech, Novo Nordisk, and Takeda sharing strategies for effective commercialization and engagement PLEASANTON, Calif., April 17, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that leaders from Bayer, Genentech, Novo Nordisk, Takeda, and others will be among the keynote speakers at the 2024 Veeva Commercial Summit, May 7-8 in Boston. Commercial and medical affairs...Read more


Veeva Systems Announces Vault CRM Campaign Manager

April 17
Last Trade: 209.65 -1.73 -0.82

Marketing automation with seamless integration to sales drives customer centricity PLEASANTON, Calif., April 17, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Vault CRM Campaign Manager, a new industry-specific marketing application that simplifies and speeds non-personal promotion to healthcare professionals. Vault CRM Campaign Manager lives in the same Vault as Veeva Vault CRM and shares the same customer...Read more


SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)

April 17
Last Trade: 4.61 -0.03 -0.65

European-based Unilabs has deployed the SOPHiA DDM™ Platform across its network in Switzerland to support cancer diagnostics and treatment BOSTON and ROLLE, Switzerland, April 17, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Unilabs, one of the largest diagnostic providers in Europe, and the only provider to offer laboratory,...Read more


SHL Telemedicine Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones

April 17
Last Trade: 5.38 0.49 10.02

TEL AVIV, Israel & ZURICH & NEW YORK / Apr 17, 2024 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT; SIX Swiss Exchange: SHLTN) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, announced today its results for the full-year 2023, highlighting fiscally responsible growth across all regions and a strategic focus on expansion and innovation. In 2023, SHL Telemedicine achieved...Read more


Sign Up To Get Daily Life Science Stock News

Please review our Disclaimer and Privacy Policy before subscribing.

Featured Stock

Surmodics

Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic immunoassay tests and microarrays. Surmodics is pursuing highly differentiated whole-product solutions that are designed to address...

CLICK TO LEARN MORE

COPYRIGHT ©2023 HEALTH STOCKS HUB